1.17
price up icon12.50%   0.13
after-market アフターアワーズ: 1.23 0.06 +5.13%
loading
前日終値:
$1.04
開ける:
$1.04
24時間の取引高:
1.41M
Relative Volume:
1.90
時価総額:
$129.99M
収益:
$100.56M
当期純損益:
$-119.05M
株価収益率:
-0.9512
EPS:
-1.23
ネットキャッシュフロー:
$-231.16M
1週間 パフォーマンス:
-10.00%
1か月 パフォーマンス:
+19.46%
6か月 パフォーマンス:
-79.65%
1年 パフォーマンス:
-77.50%
1日の値動き範囲:
Value
$1.01
$1.215
1週間の範囲:
Value
$0.9728
$1.295
52週間の値動き範囲:
Value
$0.87
$6.78

Alector Inc Stock (ALEC) Company Profile

Name
名前
Alector Inc
Name
セクター
Healthcare (1153)
Name
電話
415-231-5660
Name
住所
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Name
職員
238
Name
Twitter
Name
次回の収益日
2024-12-05
Name
最新のSEC提出書
Name
ALEC's Discussions on Twitter

ALEC を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ALEC
Alector Inc
1.17 129.99M 100.56M -119.05M -231.16M -1.23
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
424.99 128.84B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
527.78 65.38B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
549.65 39.67B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.15 33.82B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ONC
Beigene Ltd Adr
231.99 27.60B 3.81B -644.79M -669.77M -6.24

Alector Inc Stock (ALEC) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-17 ダウングレード Mizuho Outperform → Neutral
2024-12-16 ダウングレード Stifel Buy → Hold
2024-12-04 ダウングレード BofA Securities Neutral → Underperform
2024-11-29 繰り返されました H.C. Wainwright Buy
2024-11-26 ダウングレード Morgan Stanley Equal-Weight → Underweight
2023-12-14 アップグレード Stifel Hold → Buy
2023-12-12 開始されました Deutsche Bank Buy
2023-09-25 開始されました Goldman Sell
2023-09-22 開始されました Cantor Fitzgerald Overweight
2023-01-06 ダウングレード BofA Securities Buy → Neutral
2022-09-09 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-07-07 開始されました Mizuho Buy
2022-04-13 開始されました Goldman Sell
2022-03-08 ダウングレード Stifel Buy → Hold
2021-09-27 開始されました William Blair Outperform
2021-01-15 再開されました BofA Securities Buy
2020-06-24 開始されました H.C. Wainwright Buy
2020-04-28 開始されました Goldman Buy
2020-03-06 開始されました Citigroup Buy
2020-02-27 開始されました Barclays Overweight
2020-02-19 開始されました Stifel Buy
2019-11-21 開始されました BTIG Research Buy
2019-03-04 開始されました Barclays Overweight
2019-03-04 開始されました BofA/Merrill Buy
2019-03-04 開始されました Morgan Stanley Overweight
2019-03-04 開始されました SVB Leerink Outperform
すべてを表示

Alector Inc (ALEC) 最新ニュース

pulisher
01:33 AM

Alector (ALEC) Maintains Buy Rating as Price Target Increases | ALEC Stock News - GuruFocus

01:33 AM
pulisher
09:00 AM

Alector (ALEC) Price Target Raised by H.C. Wainwright | ALEC Stock News - GuruFocus

09:00 AM
pulisher
May 08, 2025

Alector Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 08, 2025
pulisher
May 08, 2025

Alector (ALEC) Reports Q1 Revenue Shortfall, Advances Drug Trials | ALEC Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Alector reports Q1 EPS (41c), consensus (46c) - TipRanks

May 08, 2025
pulisher
May 08, 2025

Alector Inc Reports Q1 2025 Earnings: EPS Loss of $0.41 Beats Estimates, Revenue Falls Short at $3.7 Million - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Alector, Inc. SEC 10-Q Report - TradingView

May 08, 2025
pulisher
May 08, 2025

Alector Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

May 08, 2025
pulisher
May 06, 2025

Alector to Participate in Upcoming Healthcare Conferences - GlobeNewswire

May 06, 2025
pulisher
May 06, 2025

Alector Sets Stage for Major Healthcare Conference Appearances: BofA and H.C. Wainwright Presentations Coming Up - Stock Titan

May 06, 2025
pulisher
May 06, 2025

Alector, Inc. (NASDAQ:ALEC) Position Raised by Invesco Ltd. - Defense World

May 06, 2025
pulisher
May 05, 2025

Alector Inc (NASDAQ: ALEC) Analysts Expect It Could Climb 71.8% From Current Levels. - Stocksregister

May 05, 2025
pulisher
May 05, 2025

Alector, Inc. (NASDAQ:ALEC) Stock Catapults 27% Though Its Price And Business Still Lag The Industry - simplywall.st

May 05, 2025
pulisher
May 02, 2025

Alector Inc (ALEC) shows promising results - uspostnews.com

May 02, 2025
pulisher
May 02, 2025

Alector Inc [ALEC] Shares Fall Approximately -76.81% Over the Year - knoxdaily.com

May 02, 2025
pulisher
May 02, 2025

Market Highlights: Alector Inc (ALEC) Ends on a High Note at 1.22 - DWinneX

May 02, 2025
pulisher
May 01, 2025

Alector Inc (ALEC) Stock: A Comprehensive 52-Week Review - investchronicle.com

May 01, 2025
pulisher
Apr 30, 2025

XTX Topco Ltd Acquires 22,381 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World

Apr 30, 2025
pulisher
Apr 28, 2025

Geode Capital Management LLC Boosts Stake in Alector, Inc. (NASDAQ:ALEC) - Defense World

Apr 28, 2025
pulisher
Apr 28, 2025

Brokerages Set Alector, Inc. (NASDAQ:ALEC) Price Target at $3.50 - Defense World

Apr 28, 2025
pulisher
Apr 26, 2025

Alector Inc (ALEC): A Sitting Duck With -250.88% Upside Potential - Stocksregister

Apr 26, 2025
pulisher
Apr 25, 2025

Following a 75% decline over last year, recent gains may please Alector, Inc. (NASDAQ:ALEC) institutional owners - simplywall.st

Apr 25, 2025
pulisher
Apr 24, 2025

There is no way Alector Inc (ALEC) can keep these numbers up - Sete News

Apr 24, 2025
pulisher
Apr 23, 2025

A Guide To The Risks Of Investing In Alector Inc (ALEC) - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

ALEC’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com

Apr 23, 2025
pulisher
Apr 23, 2025

Neogenomics Inc (NEO) Stock’s Detailed Analysis - Marketing Sentinel

Apr 23, 2025
pulisher
Apr 23, 2025

Alector Inc (ALEC): What Makes The Stock Good? - Marketing Sentinel

Apr 23, 2025
pulisher
Apr 23, 2025

Gentherm Inc Is A Buy Small Cap Stock: Analysts - Marketing Sentinel

Apr 23, 2025
pulisher
Apr 22, 2025

Alector, Inc. (NASDAQ:ALEC) Holdings Cut by JPMorgan Chase & Co. - Defense World

Apr 22, 2025
pulisher
Apr 21, 2025

Alector concludes enrolment in Phase II trial of Alzheimer’s treatment - Yahoo Finance

Apr 21, 2025
pulisher
Apr 18, 2025

What Analysts Were Expecting After Alector Inc (NASDAQ: ALEC) fell -5.95% - Stocksregister

Apr 18, 2025
pulisher
Apr 17, 2025

Alector Completes Enrollment for Phase 2 Alzheimer's Trial of AL101 - marketscreener.com

Apr 17, 2025
pulisher
Apr 17, 2025

Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease - GlobeNewswire

Apr 17, 2025
pulisher
Apr 17, 2025

Alector (ALEC) Completes Enrollment for Alzheimer's Drug Trial | - GuruFocus

Apr 17, 2025
pulisher
Apr 17, 2025

Major Milestone: Alector's Innovative Alzheimer's Drug Trial Hits Full Enrollment Ahead of Schedule - Stock Titan

Apr 17, 2025
pulisher
Apr 07, 2025

Alector stock hits 52-week low at $0.99 amid sharp decline By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

Alector stock hits 52-week low at $0.99 amid sharp decline - Investing.com India

Apr 07, 2025
pulisher
Apr 04, 2025

Alector, Inc. (NASDAQ:ALEC) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Apr 04, 2025
pulisher
Apr 03, 2025

Finance Watch: As Stocks Tumble, Offerings Slow, Financial Alternatives Rise - insights.citeline.com

Apr 03, 2025
pulisher
Apr 03, 2025

Frontotemporal Dementia Pipeline 2025: Key Companies, MOA, - openPR.com

Apr 03, 2025
pulisher
Mar 31, 2025

Alector stock hits 52-week low at $1.24 amid market challenges - Investing.com

Mar 31, 2025
pulisher
Mar 30, 2025

Charles Schwab Investment Management Inc. Reduces Stock Position in Alector, Inc. (NASDAQ:ALEC) - Defense World

Mar 30, 2025
pulisher
Mar 30, 2025

Alector, Inc. (NASDAQ:ALEC) Shares Sold by Charles Schwab Investment Management Inc. - The AM Reporter

Mar 30, 2025
pulisher
Mar 28, 2025

Alector Announces Resignation of Chief Medical Officer - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Alector Appoints New Chief Medical Officer - MarketScreener

Mar 28, 2025
pulisher
Mar 28, 2025

Alector Provides Executive Leadership Update - The Manila Times

Mar 28, 2025
pulisher
Mar 28, 2025

Alector Names Neurology Expert as CMO Amid Crucial Phase 3 Dementia Trial - Stock Titan

Mar 28, 2025
pulisher
Mar 25, 2025

Alector Cuts Staff Again, This Time Laying Off 13% of Workforce - BioSpace

Mar 25, 2025
pulisher
Mar 21, 2025

Alector, Inc. (NASDAQ:ALEC) Not Doing Enough For Some Investors As Its Shares Slump 26% - simplywall.st

Mar 21, 2025
pulisher
Mar 19, 2025

Alector stock hits 52-week low at $1.29 amid sharp annual decline - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

Alector at Virtual CNS Forum: Advancing Neurodegenerative Treatments By Investing.com - Investing.com South Africa

Mar 18, 2025

Alector Inc (ALEC) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$65.08
price down icon 0.84%
$19.36
price down icon 0.31%
$33.15
price up icon 0.15%
$23.96
price down icon 2.80%
$92.77
price down icon 2.12%
biotechnology ONC
$231.99
price down icon 1.67%
大文字化:     |  ボリューム (24 時間):